Ebola is a deadly hemorrhagic disease caused by a virus that is endemic in parts of East-Central and West Africa. Most people are aware that a primary route for person-to-person transmission is ...

Ebola is a deadly hemorrhagic disease caused by a virus that is endemic in parts of East-Central and West Africa. Most people ...

A groundbreaking study has unveiled how the Ebola virus can traverse through layers of human skin, potentially facilitating direct transmission through touch. This highlights critical cellular targets ...

Yorkville agreed to advance to FibroBiologics the first $15 million available under the SEPA in three equal tranches to be evidenced by convertible promissory notes. The first tranche in the amount of ...

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

19, 2024 — A study provides insights into the diversity of cancer-associated fibroblasts in white and ... to drive tumor growth in breast cancer cells that carry its receptors, but a new study ...

A new study from Karolinska Institutet maps the cellular and molecular dynamics of human wound healing in exceptional detail.

Cardiovascular disease continues to lead as the primary cause of death across the globe, taking millions of lives every year.

Cardiovascular disease continues to lead as the primary cause of death across the globe, taking millions of lives every year.

Researchers at Korea University have achieved a significant breakthrough in regenerative medicine. They have demonstrated how ...

The agreement allows FibroBiologics, subject to customary conditions, to sell up to $25 million in the aggregate of its common stock to Yorkville over the course of two years. Yorkville agreed to ...